Waleed H. Hassanein - Feb 23, 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
President & CEO, Director
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
Feb 23, 2024
Transactions value $
$0
Form type
4
Date filed
2/27/2024, 05:00 PM
Previous filing
Dec 5, 2023
Next filing
Apr 12, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Award $0 +36.8K +7.25% $0.00 543K Feb 23, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +56.6K $0.00 56.6K Feb 23, 2024 Common Stock 56.6K $83.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 36,755 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 23, 2024 until the option is fully vested on February 23, 2028, subject to continued service.